Aron Gewirtzman
Dermatology · Wilmington, NCNPI 1043478761
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by AbbVie at 34.8% of the total. Reporting peaked in 2022 at $7,305 and has fallen 95.0% since, to $366 in 2023. Among dermatology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 575 payments — averaging $29.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Pfizer$3K
- Johnson & Johnson$1K
- Almirall LLC$818
- Mayne Pharma Commercial LLC$716
- UCB, Inc.$674
- plus $5K from 27 others
Across 84 payments — averaging $2809.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$207K
- Principia Biopharma Inc.$23K
- Sanofi US Services Inc.$6K
What the payments were for
- Consulting fees$5,68833%
- Travel & lodging$1,63910%
- Food & beverage$9,52755%
- Education$3842%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 66 | $6,006 |
| Pfizer | 38 | $2,894 |
| Johnson & Johnson | 107 | $1,281 |
| Almirall LLC | 2 | $818 |
| Mayne Pharma Commercial LLC | 51 | $716 |
| UCB, Inc. | 31 | $674 |
| Sanofi | 31 | $621 |
| VYNE Pharmaceuticals Inc. | 38 | $594 |
| Regeneron Healthcare Solutions, Inc. | 28 | $590 |
| Novartis | 25 | $524 |
| Sun Pharmaceutical Industries Inc. | 23 | $363 |
| Galderma Laboratories, L.p. | 26 | $313 |
| LEO Pharma Inc. | 12 | $233 |
| E.r. Squibb & Sons, L.L.C. | 7 | $230 |
| Lilly USA, LLC | 15 | $229 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 16 | $225 |
| Journey Medical Corporation | 12 | $180 |
| EPI Health, LLC | 11 | $177 |
| Incyte Corporation | 10 | $140 |
| Dermira, Inc. | 4 | $65 |
| Genentech USA, Inc. | 4 | $59 |
| Aclaris Therapeutics, Inc. | 3 | $50 |
| Biofrontera Inc. | 3 | $48 |
| Amgen | 3 | $40 |
| Arcutis Biotherapeutics, Inc. | 1 | $32 |
| Organogenesis Inc. | 1 | $22 |
| Mission Pharmacal Company | 1 | $22 |
| Promius Pharma LLC | 1 | $17 |
| Strata Skin Sciences, Inc. | 1 | $17 |
| Prugen, Inc. Pharmaceuticals | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,238 in reported general payments places this provider in the 90th percentile of 475 dermatology providers in North Carolina.
Other dermatology in Wilmington
- Rosalyn GeorgeWilmington$346K
- Laura TannerWilmington$54K
- Jonathan CraneWilmington$14K
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- William HooverConcord$594K
- Patrick McElgunnCharlotte$565K
- George MagelHickory$554K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.